参考文献/References:
[1]蒋天宇,马君俊,臧潞,等.胃空肠转流术联合转化治疗后根治性切除治疗胃癌合并幽门梗阻的临床疗效[J].中华消化外科杂志,2021,20(9):967-973.[2]Wang HH,Angeli TR,Beban G,et al.Slow wave coupling across a gastroduodenal anastomosis as a mechanism for post-surgical gastric dysfunction: evidence for a "Gastric Aberrant Pathway"[J].AJP Gastrointestinal and Liver Physiology,2019,317(2):G141-G146.[3]张震,苏妍卓,李畅,等.胃肠吻合术联合术后化疗治疗不能根治切除伴幽门梗阻的进展期胃癌[J].中国普外基础与临床杂志,2019,26(11):1342-1345.[4]张一帆.全腹腔镜下远端胃切除术联合三角吻合术治疗胃癌的临床研究[J].实用癌症杂志,2021,36(9):1521-1523,1527.[5]Lakshmana R,Sivamarieswaran R,Gopinathan A.A comparative study on the outcome of stapler anastomosis vs. hand-sewn anastomosis in elective gastrointestinal surgeries[J].Journal of Evolution of Medical and Dental Sciences,2018,7(19):2303-2308.[6]刘昊,徐泉,马福海,等.全腹腔镜胃部分离断后胃肠吻合术治疗胃癌合并幽门梗阻的临床效果[J].中华肿瘤杂志,2020,42(6):445-448.[7]中华医学会肿瘤学分会,中华医学会杂志社.中华医学会胃癌临床诊疗指南(2021版)[J].中华医学杂志,2022,102(16):1169-1189.[8]吴楚营,叶凯,许建华,等.改良Overlap吻合与传统辅助切口吻合在腹腔镜全胃根治术中的临床疗效[J].中华消化外科杂志,2020,19(9):988-994.[9]田庆林,李阳,陈晓峰.腹腔镜远端胃癌根治术毕Ⅱ式联合Braun吻合术对胃癌肠道屏障功能血清炎性因子水平的影响[J].河北医学,2020,26(1):41-45.[10]张洪志,任远,张旭,等.胃癌伴幽门梗阻患者的腹腔镜手术价值探讨[J].实用临床医药杂志,2020,24(21):9-11.[11]周典伟,徐建华,胡宁,等.全腹腔镜下单纯毕Ⅱ式及毕Ⅱ式联合Braun吻合治疗远端胃癌的临床比较[J].现代消化及介入诊疗,2019,24(6):618-622.[12]张峰,朱求实,王满贞,等.毕Ⅱ式吻合术联合改良Braun吻合术对腹腔镜远端胃癌切除术患者的临床疗效及安全性[J].癌症进展,2019,17(3):315-317.[13]刘天舟,刘晶晶,乔小放,等.腹腔镜胃部分离断后胃肠吻合术治疗胃出口型梗阻1例报告[J].中国实用外科杂志,2018,38(11):1318-1319,1321.[14]李婷,赵平武.完全腹腔镜胃癌根治术腔内食管空肠侧侧吻合的临床应用研究[J].腹腔镜外科杂志,2018,23(10):761-765.[15]唐滔,叶进军,李德宁,等.全腹腔镜下改良三角吻合技术在胃癌根治术中临床应用[J].中国现代普通外科进展,2018,21(6):441-443,465.[16]景东帅,雷亮亮,张丽柯,等.全腹腔镜胃部分离断后胃肠吻合术对老年胃癌合并幽门梗阻的远期临床疗效分析[J].中国现代普通外科进展,2022,25(4):283-286.[17]杨海涛,匡荣康.全腹腔镜下三角吻合术进行胃癌远端胃切除术消化道重建的安全性和可行性[J].实用癌症杂志,2017,32(10):1738-1740.[18]罗建飞,闫瑞承,赫杰,等.全腹腔镜全胃癌根治术食管右侧近端空肠Roux-en-Y吻合消化道重建的临床应用[J].临床外科杂志,2017,25(10):765-767.[19]甄雄严,宋雪云,张文缙,等.两种术式治疗胃癌合并幽门梗阻的近远期疗效比较[J].实用临床医药杂志,2017,21(15):125-127.[20]仇广林,魏超,朱梦珂,等.早期胃上部癌腹腔镜近端胃切除双通道吻合与腹腔镜全胃切除Roux-en-Y吻合两种消化道重建术式的疗效比较[J].中华胃肠外科杂志,2022,25(5):412-420.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息官方网站,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Medical Information,2018,31(15):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息官方网站,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Medical Information,2018,31(15):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息官方网站,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Medical Information,2018,31(15):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息官方网站,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Medical Information,2018,31(15):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息官方网站,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(15):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[6]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息官方网站,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Medical Information,2018,31(15):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[7]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息官方网站,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Medical Information,2018,31(15):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[8]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息官方网站,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Medical Information,2018,31(15):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[9]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息官方网站,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Medical Information,2018,31(15):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[10]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息官方网站,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Medical Information,2019,32(15):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]